Connect with us

Technology

Respected pharma data science pioneer Dr Ben Sidders to spearhead Biorelate’s next growth phase as Chief Scientific Officer

Published

2 weeks ago

on

* Dr Sidders brings two decades of deep data science experience, honed across multiple therapeutic areas at Pfizer and AstraZeneca * He will build on Biorelate’s strong track record of leveraging advanced data science methods to extract critical knowledge from vast amounts of biomedical literature * These new data-derived insights are enabling drug developers to identify new targets with maximum market potential.

MANCHESTER, England, Sept. 5, 2024 /PRNewswire-PRWeb/ — Biorelate has announced the appointment of leading pharmaceutical industry data science expert, Dr Ben Sidders, as Chief Scientific Officer. Formerly Executive Director, Head of Early Data Science at AstraZeneca within Oncology R&D, Dr Sidders will spearhead a new growth phase for Biorelate, which leverages advanced data science methods to transform the focus and impact of drug discovery and development.

This prestigious appointment is an important endorsement of the great work we are doing, and we are delighted to welcome Ben on board. His scientific direction will give Biorelate an even deeper footing within modern drug discovery and development.

Dr Sidders has spent two decades leading data science teams at both AstraZeneca and Pfizer, to pioneer and apply novel data science methods for drug discovery in oncology, neuroscience and infectious disease.

Biorelate specialises in advanced data science methods for drug discovery to deliver robust, evidence-based intelligence to those making critical decisions about the next drugs to take forward. The actionable insights it distils, from across diverse ‘dark’ (previously unsearchable) knowledge assets and existing texts, ensure that investment is concentrated on the targets most likely to succeed in drug development – with a positive impact for patients, while delivering financially for the drug developer and its backers.

Dr Sidders, who has followed Biorelate closely since the company’s foundation in 2014, believes the company is at an important inflection point thanks to its proven technology and a significant opportunity to grow and scale. That’s as drug developers look to next-generation data science to transform their early research, and improve new drug candidates’ probability of success.

Of the opportunity Biorelate addresses, Dr Sidders said: “The pharmaceutical industry is rapidly adopting data science-driven approaches using artificial intelligence. This has meant a shift away from the traditional pharma R&D model (very low throughput, with heavy reliance on academic literature to determine new targets), towards an Artificial Intelligence (AI)-first approach.

“The risk with this approach is that researchers do not really understand the causality of their findings, which is critical if you want to develop a successful drug. Biorelate fills that gap by drawing on a wealth of data to develop causal models and explaining – mechanistically and in the appropriate context – what the next opportunities are and why. Crucially, Biorelate’s technology platform has causality built in – something that’s lacking in other AI approaches to drug discovery. It has proven adept at finding new targets, and has promise in other areas of the pipeline too, from biomarker discovery and patient stratification to the identification of promising drug combinations. This is a really exciting time for Biorelate, and for data science in drug discovery more broadly.”

Daniel Jamieson, Biorelate’s CEO, said: “This prestigious appointment is an important endorsement of the great work we are doing, and we are delighted to welcome Ben on board. His scientific direction will give Biorelate an even deeper footing within modern drug discovery and development.

“At AstraZeneca, Ben’s team was responsible for delivering data-driven, actionable insights to all parts of the company’s oncology portfolio, including advancing the understanding of disease. His years at Pfizer, and his extensive experience of all facets of drug discovery across major pharma, add richly to his understanding of what the industry needs now to transform R&D performance – insights and expertise we can now extend to our diverse client base.”

Dr Sidders’ personal fields of interest include immuno-oncology, network biology and the role of bioinformatics within drug discovery. He has a PhD in Molecular Biology & Bioinformatics from the University of London where his thesis focused on the development of predictive markers for the diagnosis of asymptomatic Tuberculosis. Ben holds patents for two clinical diagnostics and has authored over 30 scientific publications.

About Biorelate

Biorelate is a world leader in leveraging advanced data science methods to extract critical knowledge from vast amounts of pharmaceutical data and literature, significantly enhancing the discovery of novel biopharmaceuticals. Biorelate offers multiple product lines powered by its proprietary platform, Galactic AI™.

Galactic AI™ employs sophisticated natural language processing (NLP) and artificial intelligence (AI) to uncover hidden cause- and-effect relationships. This innovative platform provides unprecedented insights into disease pathways, enabling more precise and effective drug discovery. As the incredible progress of scientific researchers continues to compound the huge volume of growing and evolving biomedical data, Biorelate’s mission to curate knowledge to advance the world’s most promising biomedical innovations has never been so important.

Media Contact

Mira Nair, Biorelate, 44 07799153550, mira.nair@biorelate.com, https://biorelate.com/

View original content to download multimedia:https://www.prweb.com/releases/respected-pharma-data-science-pioneer-dr-ben-sidders-to-spearhead-biorelates-next-growth-phase-as-chief-scientific-officer-302239087.html

SOURCE Biorelate

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BASX Hosts Ribbon-Cutting Ceremony for New State-of-the-Art Weld Shop

Published

28 mins ago

on

September 19, 2024

By

REDMOND, Ore., Sept. 19, 2024 /PRNewswire/ — BASX (“BASX” or the “Company”), a leader in the manufacturing of high-efficiency data center cooling solutions, cleanroom systems, and custom HVAC systems, is proud to announce the official ribbon-cutting ceremony for its newly completed 36,000-square-foot weld shop. The Redmond Chamber of Commerce performed the ribbon cutting on September 18th, 2024, at BASX headquarters.

The weld shop will create significant job opportunities in the Central Oregon region, with the capacity to fill an additional 30 welding positions. Positions range from entry-level to experienced roles, with professional opportunities in various growing departments within the Company.

“This new facility is a major investment not just in our company, but in the future of Central Oregon,” said Dave Benson, AAON VP and BASX President. “We can now deliver even higher levels of quality and efficiency while providing more job opportunities for the community. We’re proud to support local manufacturing growth and look forward to seeing the impact this expansion will have on both BASX and the region.”

The new shop marks a major expansion in the Company’s production capabilities, introducing state-of-the-art welding technology within a climate-controlled environment. Equipped with advanced air filtration systems, including an AAON make-up air unit and multiple air scrubbers, the shop ensures exceptional air quality for its workers. The space also features two 5-ton overhead cranes and six ½-ton cantilever jib cranes, allowing for efficient movement of materials across the facility.

A key highlight of the facility is its cutting-edge tube laser, capable of precision cutting and profiling round and square tubes, as well as C-channel and I-beam profiles up to 27 feet in length. Additionally, a 75-foot-long dual-zone robotic welding cell is scheduled to be installed and operational in early 2025, enabling the welding of large subassemblies up to 10 tons.

The shop’s innovative capabilities will support the Company’s growth and solidify its position for ongoing expansion. In addition to the 30 new welding jobs, BASX is actively hiring across various departments to support its continued success. To learn more about available positions and apply, visit the BASX careers page at www.basxsolutions.com/careers.

About BASX
Founded in 2014 in Central Oregon, BASX is an industry leader in the manufacturing of high-efficiency data center cooling solutions, cleanroom systems, custom HVAC systems, and modular solutions. Acquired by AAON in 2021, BASX continues to focus on quality, innovation, and state-of-the-art technology. The Company is proud to display the Made-in-America emblem on all its products. For more information, please visit www.basx.com.

Contact Information
Christina Lattanzio
Marketing Manager
(918) 508-9272
Email: Marketing@basx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/basx-hosts-ribbon-cutting-ceremony-for-new-state-of-the-art-weld-shop-302253745.html

SOURCE AAON

Continue Reading

Technology

NASA Sets Coverage for Astronaut Tracy C. Dyson, Crewmates Return

Published

28 mins ago

on

September 19, 2024

By

WASHINGTON, Sept. 19, 2024 /PRNewswire/ — NASA astronaut Tracy C. Dyson, accompanied by Roscosmos cosmonauts Nikolai Chub and Oleg Kononenko, will depart from the International Space Station aboard the Soyuz MS-25 spacecraft, and return to Earth.

Dyson, Chub, and Kononenko will undock from the orbiting laboratory’s Prichal module at 4:37 a.m. EDT Monday, Sept. 23, heading for a parachute-assisted landing at 8 a.m. (5 p.m. Kazakhstan time) on the steppe of Kazakhstan, southeast of the town of Dzhezkazgan.

NASA’s live coverage of return and related activities will stream on NASA+ and the agency’s website. Learn how to stream NASA content through a variety of platforms, including social media.

A change of command ceremony also will stream on NASA platforms at 10:15 a.m. Sunday, Sept. 22. Kononenko will hand over station command to NASA astronaut Suni Williams for Expedition 72, which begins at the time of undocking.

Spanning 184 days in space, Dyson’s mission includes covering 2,944 orbits of the Earth and a journey of 78 million miles. The Soyuz MS-25 spacecraft launched March 23, and arrived at the station March 25, with Dyson, Roscosmos cosmonaut Oleg Novitskiy, and spaceflight participant Marina Vasilevskaya of Belarus. Novitskiy and Vasilevskaya were aboard the station for 12 days before returning home with NASA astronaut Loral O’Hara on April 6.

Kononenko and Chub, who launched with O’Hara to the station on the Soyuz MS-24 spacecraft last September, will return after 374 days in space and a trip of 158.6 million miles, spanning 5,984 orbits.

Dyson spent her fourth spaceflight aboard the station as an Expedition 70 and 71 flight engineer, and departs with Kononenko, completing his fifth flight into space and accruing an all-time record 1,111 days in orbit, and Chub, who completed his first spaceflight.

After returning to Earth, the three crew members will fly on a helicopter from the landing site to the recovery staging city of Karaganda, Kazakhstan. Dyson will board a NASA plane and return to Houston, while Kononenko and Chub will depart for a training base in Star City, Russia.

NASA’s coverage is as follows (all times Eastern and subject to change based on real-time operations):

Sunday, Sept. 22
10:15 a.m. – Expedition 71/72 change of command ceremony begins on NASA+ and the agency’s website.

Monday, Sept. 23
12:45 a.m. – Hatch closing coverage begins on NASA+ and the agency’s website.

1:05 a.m. – Hatch closing

4 a.m. – Undocking coverage begins on NASA+ and the agency’s website.

4:37 a.m. – Undocking

6:45 a.m. – Coverage begins for deorbit burn, entry, and landing on NASA+ and the agency’s website.

7:05 a.m. – Deorbit burn

8 a.m. – Landing

For more than two decades, people have lived and worked continuously aboard the International Space Station, advancing scientific knowledge, and making research breakthroughs that are not possible on Earth. The station is a critical testbed for NASA to understand and overcome the challenges of long-duration spaceflight and to expand commercial opportunities in low Earth orbit. As commercial companies focus on providing human space transportation services and destinations as part of a robust low Earth orbit economy, NASA is focusing more resources on deep space missions to the Moon as part of Artemis in preparation for future human missions to Mars.

Learn more about International Space Station research and operations at:

https://www.nasa.gov/station

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-sets-coverage-for-astronaut-tracy-c-dyson-crewmates-return-302253747.html

SOURCE NASA

Continue Reading

Technology

Global claims guidance leader EvolutionIQ joins as CALI’s inaugural Life Partner

Published

28 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 20, 2024 /PRNewswire/ — US-based EvolutionIQ, a global leader in claims guidance technology, has signed on as the Council of Australian Life Insurers (CALI)’s first Life Partner as part of its corporate partner program.

The CALI Partner Program is designed to foster collaboration and create a connected ecosystem of industry experts.

CALI Life Partners share the industry’s mission to make life insurance accessible, understandable and trusted. They are companies that support Australian life insurers to help Australians and their families have peace of mind about their future so they can live in the most healthy, confident and secure way.

“We are pleased to welcome EvolutionIQ as CALI’s inaugural Life Partner. The CALI Partner Program plays an important role in connecting our members to the latest innovators, like EvolutionIQ, that can move their businesses forward,” said CALI CEO Christine Cupitt.

“We want to work closely with each of our partners to strengthen and support the life insurance industry to deliver better customer experiences for millions of Australians on their best and worst days.”

Headquartered in New York, EvolutionIQ has expanded significantly since 2019. Its clients include major insurance carriers such as Sun Life, Reliance Matrix and Principal Financial. Their AI-powered software makes insurance claims processes more personalised, fair and cost-effective so that more people can recover faster and return to work.

“We are committed to supporting the Australian life insurance ecosystem and being a CALI Life Partner enables us to specialise our products to meet the dynamic needs of the Australian markets,” said EvolutionIQ’s Co-CEO, Mike Saltzman.

“Our partnership with CALI means we can contribute to and shape customer experiences in Australia, and ultimately help more people return to health and a livelihood sooner.”

About EvolutionIQ
EvolutionIQ pioneered Claims Guidance in 2019. Its explainable AI guides insurance claims professionals to their highest potential impact claims, improving the claimant experience and delivering better claim outcomes to claimants, carriers and their customers. EvolutionIQ serves the group disability, individual disability and workers’ compensation markets worldwide. EvolutionIQ’s AI native products have been adopted by 70% of the top 15 U.S. disability carriers and a growing list of workers’ compensation carriers. The New York-based company employs 185 staff across the United States, Europe and Australia. For more information, visit evolutioniq.com and follow the company on LinkedIn.

About CALI
We support Australians to make informed choices about their future and help them live in a healthy, confident and secure way over their lifetime.

Our members’ products and services give people peace of mind when making important decisions and provide a financial safety net during life’s biggest challenges.

We advocate for national policy settings that expand Australians’ access to the life insurance protection that suits them when they need it most.

CALI represents all life insurers and reinsurers in Australia. The Australian life insurance industry is today a $26.4billion industry, employing thousands of Australians and paying billions of dollars of benefits each year.

To view CALI’s corporate partners visit www.cali.org.au/about-us/#our-partners

For more information, visit www.cali.org.au

Media Contact
Jason Kapler
Vice President of Marketing
EvolutionIQ
(917) 740-5608
Press@evolutioniq.com

Logo – https://mma.prnewswire.com/media/1723642/EvolutionIQ_Logo.jpg
Logo – https://mma.prnewswire.com/media/2509100/CALI_logo.jpg

View original content:https://www.prnewswire.com/apac/news-releases/global-claims-guidance-leader-evolutioniq-joins-as-calis-inaugural-life-partner-302253427.html

SOURCE EvolutionIQ

Continue Reading

Trending